Showing results (151-160 of 324) with videos related to

Sort By:
Pageof 33
British Journal of Cancer|December 1, 1978
Monitoring salivary misonidazole in man: a possible alternative to plasma monitoringP Workman, C R Wiltshire, P N Plowman, et al.
British Journal of Cancer|April 1, 1980
Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouseD J Honess, P Workman, J E Morgan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 1994
Relative importance of DT-diaphorase and hypoxia in the bioactivation of EO9 by human lung tumor cell linesJ A Plumb, M Gerritsen, R Milroy, et al.
British Journal of Cancer|August 1, 1979
The penetration of misonidazole into spontaneous canine tumoursR A White, P Workman, L N Owen, et al.
Breast (Edinburgh, Scotland)|March 24, 2007
Clinical efficacy of capecitabine as first-line chemotherapy in metastatic breast cancer--how low can you go?Y S Yap, A Kendall, G Walsh, et al.
Anti-Cancer Drug Design|September 1, 1996
Synthesis and anti-cancer activity of 2,6-disubstituted N-methylpiperidine derivatives and their N-oxidesN D Henderson, J A Plumb, D J Robins, et al.
British Journal of Cancer|November 17, 2001
Measuring changes in human tumour vasculature in response to therapy using functional imaging techniquesH Anderson, P Price, M Blomley, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Pharmacokinetics of BW12C and mitomycin C, given in combination in a phase 1 study in patients with advanced gastrointestinal cancerI F Dennis, J R Ramsay, P Workman, et al.
Pageof 33